Status:
TERMINATED
Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure
Lead Sponsor:
Ziekenhuis Netwerk Antwerpen (ZNA)
Conditions:
Renal Insufficiency, Acute
Renal Replacement Therapy
Eligibility:
All Genders
18+ years
Brief Summary
This multicentre SHARF4 (Stuivenberg Hospital Acute Renal Failure) study aims to investigate outcome in patients with acute renal failure (ARF), stratified according to severity of disease (SHARF scor...
Detailed Description
Subjects. Hospitals qualified for participation if they had at least 600 beds, a centre for the treatment of End Stage Kidney Disease (ESKD) patients, a multipurpose ICU with at least 12 beds, at leas...
Eligibility Criteria
Inclusion
- adults (\>17 years)
- having acute renal failure: serum creatinine \> 2 mg/dl
- being in need for chronic renal replacement therapy (the decision to treat conservatively or to start RRT was at the discretion of the attending physician, taking into account the rules of good clinical practice in this field)
Exclusion
- patients with known pre-existing chronic renal disease, defined as a serum creatinine above 1.5 mg/dl or with clearly reduced kidney size on ultrasound were excluded.
Key Trial Info
Start Date :
April 1 2001
Trial Type :
OBSERVATIONAL
End Date :
March 1 2005
Estimated Enrollment :
1628 Patients enrolled
Trial Details
Trial ID
NCT00322933
Start Date
April 1 2001
End Date
March 1 2005
Last Update
October 26 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Lins
Antwerp, Belgium, 2170